# US 2013/0253017 A1 · Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filmament

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253017 A1
- Document ID: US20130253017A1
- Status: Published application
- Kind: A1
- Application number: 13/893,373
- Filed: 2013-05-14
- Published: 2013-09-26
- Earliest claimed: 2010-07-02
- Assignees: The Procter & Gamble Company
- Applicants: The Procter & Gamble Company
- Inventors: Trevor John Darcy; Steven Ray Gilbert; Gregory Charles Gordon; Rajeev Chhabra; William Maxwell Allen, JR.
- Web page: https://patentgrep.com/patent/US20130253017A1

## CPC

- A61K 9/70: Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- D01D 4/025: {Melt-blowing or solution-blowing dies}
- D01F 1/10: Other agents for modifying properties
- D04H 1/728: by electro-spinning {(electro-spinning methods and apparatus D01D5/0007)}
- D04H 3/16: with bonds between thermoplastic filaments produced in association with filament formation, e.g. immediately following extrusion
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01F: CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D04H: MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL (weaving D03; knitting D04B; braiding D04C; net-making D04G; sewing D05B; tufting D05C; finishing non-woven fabrics D06); FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING {; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION}(non-woven fabrics having an intermediate or external layer of a different kind, e.g. of woven fabric, B32B)

## Abstract

A method of delivering a health care active having the steps of administering to a mammal in need of a health benefit or a treatment for a health condition a personal health care article and consuming the article. The article contains one or more filaments that contain a backbone material, a health care active and optionally aesthetic agents, extensional aids, plasticizers, and crosslinking agents.

## Claims

### Claim 1

A personal health care article comprising one or more filaments comprising:
a. from about 10% to about 80%, by weight on a dry filament basis, of a backbone material;
b. greater than about 50%, by weight on a dry filament basis, of a health care active wherein said health care active is releasable from said filament wherein said filament is exposed to conditions of intended use; and
c. less than about 20%, by weight of the filament, moisture.

### Claim 2 (depends on 1)

The article of claim 1, wherein the article has a basis weight of from about 20 g/m2 to about 1000 g/m2.

### Claim 3 (depends on 1)

The article of claim 1, wherein said filament is a meltblown filament.

### Claim 4 (depends on 1)

The article of claim 1, wherein said filament is a fluid film fibrillation filament.

### Claim 5 (depends on 1)

The article of claim 1, wherein said backbone material is selected from the group consisting of polymers, sugars, and combinations thereof.

### Claim 6 (depends on 1)

The article of claim 1, wherein said backbone material is a polymer.

### Claim 7 (depends on 6)

The article of claim 6, wherein said polymer is polyvinyl alcohol, pullulan, pectin, corn starch, modified corn starch, or hydroxypropyl methylcellulose.

### Claim 8 (depends on 6)

The article of claim 6, wherein said polymer is selected from the group consisting of naturally sourced polymers, synthetic polymers, and combinations thereof.

### Claim 9 (depends on 6)

The article of claim 6, wherein said naturally sourced polymer is selected from the group consisting of alginates, starch based polymers, native starches, modified starches, and combinations thereof.

### Claim 10 (depends on 6)

The article of claim 6, wherein said polymer exhibits a weight average molecular weight of from about 20,000 Da to about 200,000 Da.

### Claim 11 (depends on 6)

The article of claim 6, wherein said polymer exhibits a weight average molecular weight of from about 1,000,000 Da to about 6,000,000 Da.

### Claim 12 (depends on 1)

The article of claim 1, further comprising a filament-forming material selected from the group consisting of extensional aids, plasticizers, crosslinking agents, and combinations thereof.

### Claim 13 (depends on 1)

The article of claim 1, wherein said filament comprises two or more different backbone materials.

### Claim 14 (depends on 1)

The article of claim 1, wherein said filament comprises greater than about 25%, by weight on a dry filament basis, one or more health care actives.

### Claim 15 (depends on 1)

The article of claim 1, wherein said filament comprises greater than about 40%, by weight on a dry filament basis, one or more health care actives.

### Claim 16 (depends on 1)

The article of claim 1, wherein said health care active is selected from the group consisting of respiratory agents, gastrointestinal agents, central nervous system agents, anti-infective agents, nutritional agents, overall wellbeing agents, and combinations thereof.

### Claim 17 (depends on 1)

The article of claim 1, wherein said filament comprises two or more different health care actives.

### Claim 18 (depends on 1)

The article of claim 1, wherein said filament further comprises an aesthetic agent wherein said aesthetic agent is selected from the group consisting of flavors, colorants, sensates, sweeteners, salivation agents, and combinations thereof.

### Claim 19

A personal health care article comprising one or more filaments comprising:
a. from about 10% to about 80%, by weight on a dry filament basis, of a backbone material;
b. greater than about 10%, by weight on a dry filament basis, of a health care active wherein said health care active is releasable from said filament wherein said filament is exposed to conditions of intended use wherein the health care active comprises pharmaceutically acceptable salts of bismuth; and
c. less than about 20%, by weight of the filament, moisture.
